41.8
Galectin Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
20.6
FY23:
27.7
FY24:
17.3
FY25:
19.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.73
FY23:
0.49
FY24:
0.24
FY25:
0.10
Total assets
Change from FY21 to FY25
millions USD
FY21:
41.8
FY22:
21.3
FY23:
28.2
FY24:
17.5
FY25:
19.5
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
9.03
FY22:
13.0
FY23:
15.7
FY24:
35.4
FY25:
8.03
(negative)
Change from FY21 to FY25
millions USD
FY21:
30.2
FY22:
40.5
FY23:
72.8
FY24:
85.2
FY25:
138
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.89
FY22:
−33.9
FY23:
−62.0
FY24:
−105
FY25:
−128
All amounts in millions USD